Newborn Drug Testing - Meconium and Umbilical Cord Tissue
Exposure to maternal drug use during gestation may adversely affect neonatal development and may lead to acute adverse events, including neonatal abstinence syndrome (NAS) and infant mortality. Prenatal drug exposure may also contribute to long-term behavioral effects and developmental deficits.
Timely detection of in utero drug exposure is critical for effective detection and management of intoxication, withdrawal syndrome, and long-term needs (social and medical) for exposed neonates.
Detection of drugs depends on extent of maternal drug use, drug stability, drug analyte deposition in meconium and umbilical cord tissue, and performance of the analytical method.
Last Update: August 2018